ClinicalTrials.gov
ClinicalTrials.gov Menu

Lapatinib in Metastatic Breast Cancer Resistant to Hormone Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00225758
Recruitment Status : Terminated (slow accrual)
First Posted : September 26, 2005
Last Update Posted : January 14, 2015
Sponsor:
Collaborators:
University of Colorado, Denver
North Shore University Hospital
Information provided by (Responsible Party):
Dartmouth-Hitchcock Medical Center

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Terminated
  Actual Primary Completion Date : October 2011
  Actual Study Completion Date : October 2011

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 May 27, 2018